首页 | 本学科首页   官方微博 | 高级检索  
     

普米克令舒博利康尼沐舒坦雾化吸入治疗毛细支气管炎疗效观察
引用本文:王吉安. 普米克令舒博利康尼沐舒坦雾化吸入治疗毛细支气管炎疗效观察[J]. 山东医学高等专科学校学报, 2003, 25(6): 409-411
作者姓名:王吉安
作者单位:临沂医专附属临沂市人民医院,山东临沂,276003
基金项目:临沂市科技发展计划项目(NO.0202302).
摘    要:目的探讨治疗毛细支气管炎的方法.方法对109例急性毛细支气管炎患儿在给予抗病毒药及抗生素治疗的基础上,采用普米可令舒、博利康尼、沐舒坦雾化吸入治疗,并于吸药前、吸药后即刻、吸药后10min、吸药后30min、吸药后1h、吸药后3h、吸药后6h分别观测患儿的心率、呼吸频率、肺部口罗音及鼻翼扇动等指标.结果所有患儿吸药后心率、呼吸频率、肺部口罗音、鼻翼扇动等体征均即刻明显好转,且疗效维持时间>3h.结论普米克令舒、博利康尼、沐舒坦联合雾化吸入可明显减轻毛细支气管炎的症状,且维持时间较长,为毛细支气管炎的较好治疗手段.

关 键 词:普米克令舒 博利康尼 沐舒坦 毛细支气管炎 雾化吸入
文章编号:1001-5426(2003)06-0409-03
修稿时间:2003-09-14

THERAPEUTIC OBSERVATION OF NEBULIZING INHALATION OF PULMICORT BRICANLAND MUCOSOLVAN IN TREATING BRONCHIOLITS
WANG Ji'''' an. THERAPEUTIC OBSERVATION OF NEBULIZING INHALATION OF PULMICORT BRICANLAND MUCOSOLVAN IN TREATING BRONCHIOLITS[J]. Journal of Shandong Medical College, 2003, 25(6): 409-411
Authors:WANG Ji'''' an
Abstract:Objective To explore the treatment of bronchiolitis. Methods 109 cases of acute bronchiolitis received nebulizing inhalation of pulmicort, bricanyl and mucosolvan after being given antiviral drugs and antibiotics. The physical signs such as heart rate,respiratory frequency, pulmonary riles and nare flaring were closely observed before inhalation and 10 minutes,30 minutes,one hour,3 hours and 6 hours after inhalation. Results All those signs have been improved and the curative effects lasted more than 3 hours. Conclusion The therapy can effectively relieve the symptoms and the curative effects can be kept for a long time.
Keywords:Pulmicort  Bricanyl  Mucosovan  Bronchiolitis  Nebulizing inhalatioin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号